Experience using Imatinib and then Nilotinib, as second line, in patient with chronic myeloid leukemia and previous bariatric surgery. A case report
Sign Up to like & getrecommendations! Published in 2019 at "Hematology, Transfusion and Cell Therapy"
DOI: 10.1016/j.htct.2019.09.003
Abstract: has displayed better efficacy than imatinib in achieving MMR 4 hronic myeloid leukemia (CML) has become a model of sucess in the history of hematology. That is due to the possibility f discovering and monitoring… read more here.
Keywords: experience using; myeloid leukemia; using imatinib; hematology ... See more keywords